Biosimilar Monoclonal Antibody Comparability Test Platforms Market Forecast 2026–2036: Rising Biosimilar Development Accelerates Demand
The global biosimilar monoclonal antibody comparability test platforms market is expected to witness substantial growth between 2026 and 2036, fueled by the rapid expansion of biosimilar drug pipelines, increasing regulatory scrutiny, and growing investments in analytical similarity testing. According to the latest analysis by Future Market Insights (FMI), the market is being shaped by the...
0 التعليقات 0 المشاركات 27 مشاهدة 0 معاينة
إعلان مُمول